New Zealand markets closed

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.13+0.04 (+0.28%)
At close: 3:56PM EDT

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
http://www.bayer.com

Sector(s)Healthcare
IndustryDrug Manufacturers—General
Full-time employees99,439

Key executives

NameTitlePayExercisedYear born
Mr. Werner BaumannChairman of Management Board, CEO & Chief Sustainability Officer6.16MN/A1962
Mr. Wolfgang U. NicklCFO & Member of Management Board2.26MN/A1969
Mr. Liam CondonMember of Management Board & Pres Crop Science Division3.11MN/A1968
Mr. Heiko W. J. SchipperMember of Management Board & Pres of the Consumer Health Division2.84MN/A1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management3.3MN/A1968
Ms. Sarena S. LinChief Transformation & Talent Officer, Labor Director and Member of Management BoardN/AN/A1971
Mr. Bernd-Peter BierHead of Accounting and Head of TaxesN/AN/A1967
Mr. Oliver MaierHead of Investor RelationsN/AN/AN/A
Dr. Gabriel HarnierHead of Law, Patents & ComplianceN/AN/A1971
Mr. Michael PreussHead of Communications, Gov. Relations and Corp. BrandN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum Jülich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Corporate governance

Bayer Aktiengesellschaft’s ISS governance QualityScore as of 26 September 2021 is 3. The pillar scores are Audit: 2; Board: 4; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.